Exploratory identification of predictive biomarkers in randomized trials with normal endpoints
Julia Krzykalla1,2, Axel Benner1, Annette Kopp-Schneider1
1Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Statistics in Medicine
|December 22, 2019
Summary
The new predMOB method improves identifying predictive biomarkers for stratified medicine by reducing false detections. This approach enhances personalized oncological research and treatment decisions.
Area of Science:
- Biostatistics
- Oncology
- Genomics
Background:
- Personalized medicine requires identifying biomarkers to tailor treatments.
- Recursive partitioning methods are useful for capturing complex interaction patterns.
Purpose of the Study:
- To introduce predMOB, a novel adaptation of model-based recursive partitioning (MOB).
- To enhance the identification of predictive factors for stratified medicine.
Main Methods:
- Developed predMOB, an adaptation of MOB for subgroup analysis.
- Evaluated predMOB using simulation studies and a real-world amyotrophic lateral sclerosis (ALS) patient dataset.
Main Results:
- predMOB demonstrated superior performance over original MOB in simulations, with fewer false detections.
- The method proved more robust in moderately complex settings.
- Analysis of ALS data elucidated biomarker effects.
Conclusions:
- predMOB is a robust and effective tool for identifying predictive biomarkers.
- The findings support the advancement of stratified medicine and personalized oncological treatments.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
348
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
348
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:20Comparing the Survival Analysis of Two or More Groups
507
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
507
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:13Randomized Experiments
8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.8K